The Latest Cardiac and Vascular News
NeuroX Specialty Physicians to Monitor Patients Remotely Using Stratus EEG Technology GRAND RAPIDS, Mich., Oct. 15, 2020 /PRNewswire/ — NeuroX, an online Neurology and Psychology clinic, and Stratus, the leader in home EEG testing, today announced that Stratus will partner with NeuroX to provide in-home video electroencephalogram (EEG) diagnostics to patients. NeuroX is […]
Small Business Innovation Research Program Provides Seed Funding for R&D CENTREVILLE, Va., Oct. 15, 2020 /PRNewswire/ — Altrix Medical, LLC has been awarded nearly $1 million from the National Science Foundation (NSF) to continue research and development (R&D) on a miniaturized automated external defibrillator (AED). This Small Business Innovation Research (SBIR) Phase 2 cooperative agreement funds the continued development of an integrated […]
Availability of physician-prescribed cardiac monitoring system will significantly improve screening and treatment of atrial fibrillation and other chronic heart conditions. DALLAS, Oct. 15, 2020 /PRNewswire/ — LIVMOR, Inc., a leading digital health solutions company, announced today that the Company received FDA 510(k) clearance for the LIVMOR Halo™ AF Detection System, a physician-prescribed wearable […]
MONROE TOWNSHIP, N.J., Oct. 16, 2020 /PRNewswire/ — Bracco Diagnostics Inc., the U.S subsidiary of Bracco Imaging S.p.A., a leading global company in the diagnostic imaging business, announced today the FDA approval of its new CardioGen-82 infusion system to enhance automation, efficiency and simplicity in cardiac position emission tomography (PET) myocardial perfusion imaging (MPI). […]
VASCEPA®, compared with placebo, significantly reduced primary composite first and total MACE (major adverse cardiovascular events) in post hoc exploratory analyses of patients with a history of PCI by 34% and 39%, respectively, and key secondary composite first hard MACE, comprised of heart attacks, stroke and cardiovascular death, by 34% Administration of VASCEPA resulted in robust absolute risk reductions of 8.5% and 5.4% and numbers needed to treat (NNT) of 12 and 19, respectively, for both […]
If approved, inclisiran will be the first and only small interfering RNA (siRNA) in Europe for patients with hypercholesterolemia or mixed dyslipidemia1 Cardiovascular disease (CVD) claims 3.9 million lives annually in Europe2, and 80% of high-risk patients do not reach guideline-recommended low-density lipoprotein cholesterol (LDL-C) targets despite the widespread use of statins3–5 Inclisiran provides effective and sustained reduction of LDL-C of up to […]
Nine-month results from FORECAST trial show statistically significant reduction in unnecessary invasive cardiac testing, increase in catheterization lab efficiency, and reduction in repeat non-invasive testing REDWOOD CITY, Calif.–(BUSINESS WIRE)–Late-breaking results presented today confirm that incorporating the HeartFlow® FFRct Analysis into a coronary computed tomography angiogram (CTA)-led diagnostic pathway significantly increases overall […]
EDGEWOOD, Ky., Oct. 15, 2020 /PRNewswire/ — Dr. Mohamad Sinno recently performed the first implantation in the U.S. of a Bluetooth-enabled biventricular implantable cardiac defibrillator (ICD) at St. Elizabeth Edgewood. The new device, the Abbott Gallant, recently received FDA approval for a new technology assessment and is available in only a few centers in the U.S. […]
Positive Disrupt CAD III Data Submitted to FDA in Premarket Approval Application SANTA CLARA, Calif., Oct. 15, 2020 (GLOBE NEWSWIRE) — Shockwave Medical, Inc. (NASDAQ: SWAV), a pioneer in the development and commercialization of Intravascular Lithotripsy (IVL) to treat severely calcified cardiovascular disease, announced today that the coronary Investigational Device […]
Dr. Felker and Dr. Udelson join current advisors to support the development of alfapump® DSR for the management of fluid overload in patients with heart failure GHENT, Belgium, Oct. 15, 2020 (GLOBE NEWSWIRE) — Sequana Medical NV (Euronext Brussels: SEQUA), an innovator in the management of fluid overload in liver disease, malignant ascites and heart failure, today announces the appointments of Dr. Michael […]
